Abstract
Objective of the research: to assess the prevalence and course of COVID-19 in children and adolescents with cystic fibrosis (CF) in the Russian Federation. Materials and methods: up to September 1, 2020, 10 cases of COVID-19 in CF patients were registered. Results: the incidence of COVID-19 among children and adolescents with CF up to September 1, 2020 was 3,4:1000. Asymptomatic course was noted in 3 children, mild – in 5, moderate – in 2 (20%) with pneumonia. The main symptoms were fiver (60% – 6 children), increased cough – 5 (50%) and fatigue – in 3 children (30%), in 2 patients (20%) abdominal syndrome. All patients received dornase alfa inhalations, two patients received azythromycin for anti-inflammatory purposes and permanent antibacterial therapy. These factors may play a role in the milder course of COVID-19 in children and adolescents with CF.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
